Incidence, Disability, and Mortality in Patients With Guillain-Barré Syndrome in Korea: A Nationwide Population-Based Study

키워드

참고문헌 (51)

1. Israeli E, "Guillain-Barré syndrome--a classical autoimmune disease triggered by infection or vaccination", Clin Rev Allergy Immunol, 42, pp.121~130 (2012)
2. Jacobs BC, "The spectrum of antecedent infections in Guillain-Barré syndrome : a case-control study", Neurology, 51, pp.1110~1115 (1998)
3. McGrogan A, "The epidemiology of Guillain-Barré syndrome worldwide. A systematic literature review", Neuroepidemiology, 32, pp.150~163 (2009)
4. Sejvar JJ, "Population incidence of Guillain-Barré syndrome : a systematic review and meta-analysis", Neuroepidemiology, 36, pp.123~133 (2011)
5. Chen Y, "Population incidence of Guillain-Barré syndrome in parts of China : three large populations in Jiangsu province, 2008–2010", Eur J Neurol, 21, pp.124~129 (2014)
6. Rivera-Lillo G, "Incidence of Guillain-Barré syndrome in Chile : a population-based study", J Peripher Nerv Syst, 21, pp.339~344 (2016)
7. van den Berg B, "Mortality in Guillain-Barré syndrome", Neurology, 80, pp.1650~1654 (2013)
8. Lee H, "Incidence of Guillain-Barré syndrome is not associated with influenza vaccination in the elderly", Vaccines(Basel), 8, pp.431~ (2020)
9. Kim C, "Pandemic influenza A vaccination and incidence of Guillain–Barré syndrome in Korea", Vaccine, 33, pp.1815~1823 (2015)
10. Park HJ, "Prevalence, mortality, and cause of death in Charcot-Marie-Tooth disease in Korea : a nationwide, population-based study", Neuroepidemiology, 54, pp.313~319 (2020)
11. 김지애, "Towards Actualizing the Value Potential of Korea Health Insurance Review and Assessment (HIRA) Data as a Resource for Health Research: Strengths, Limitations, Applications, and Strategies for Optimal Use of HIRA Data", Journal of Korean Medical Science, 32(5), pp.718~728 (2017), 대한의학회
12. Hong JM, "Prevalence and socioeconomic status of patients with genetic myopathy in Korea : a nationwide, population-based study", Neuroepidemiology, 53, pp.115~120 (2019)
13. Asbury AK, "Criteria for the diagnosis of Guillain-Barré syndrome", Ann Neurol, 3, pp.565~566 (1978)
14. "World (WHO 2000–2025) standard" (2020)[URL]
15. Cox DR, "Regression models and life-tables", J R Stat Soc Series B Stat Methol, 34, pp.187~202 (1972)
16. Shui IM, "Guillain-Barré syndrome incidence in a large United States cohort(2000–2009)", Neuroepidemiology, 39, pp.109~115 (2012)
17. Cheng Q, "Incidence of Guillain–Barré syndrome in Sweden 1996", Eur J Neurol, 7, pp.11~16 (2000)
18. Huang WC, "A 15-year nationwide epidemiological analysis of Guillain-Barré syndrome in Taiwan", Neuroepidemiology, 44, pp.249~254 (2015)
19. Grave C, "Seasonal influenza vaccine and Guillain-Barré syndrome : a self-controlled case series study", Neurology, 94, pp.e2168~e2179 (2020)
20. Ho TW, "Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies", Brain, 118, pp.597~605 (1995)
21. Baoxun Z, "Acute polyradiculitis(Guillain-Barré syndrome) : an epidemiological study of 156 cases observed in Beijing", Ann Neurol, 9(Suppl), pp.146~148 (1981)
22. McKhann GM, "Acute motor axonal neuropathy : a frequent cause of acute flaccid paralysis in China", Ann Neurol, 33, pp.333~342 (1993)
23. Winner SJ, "Age-specific incidence of Guillain-Barré syndrome in Oxfordshire", QJM, 77, pp.1297~1304 (1990)
24. Boucquey D, "Clinical and serological studies in a series of 45 patients with Guillain-Barré syndrome", J Neurol Sci, 104, pp.56~63 (1991)
25. Stowe J, "Investigation of the temporal association of Guillain-Barré syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database", Am J Epidemiol, 169, pp.382~388 (2009)
26. Ramírez-Zamora M, "Guillain-Barre syndrome in the paediatric age : epidemiological, clinical and therapeutic profile in a hospital in El Salvador", Rev Neurol, 48, pp.292~296 (2009)
27. Dowling PC, "Guillain-Barré syndrome in greater New York-New Jersey", JAMA, 238, pp.317~318 (1977)
28. Jiang GX, "Epidemiological features of Guillain-Barré syndrome in Sweden, 1978–93", J Neurol Neurosurg Psychiatry, 62, pp.447~453 (1997)
29. Chroni E, "Guillain–Barré syndrome in Greece : seasonality and other clinico-epidemiological features", Eur J Neurol, 11, pp.383~388 (2004)
30. Shahar E, "Current therapeutic options in severe Guillain-Barré syndrome", Clin Neuropharmacol, 29, pp.45~51 (2006)
31. Hughes RAC, "Practice parameter : immunotherapy for Guillain–Barré syndrome : report of the Quality Standards Subcommittee of the American Academy of Neurology", Neurology, 61, pp.736~740 (2003)
32. Rees JH, "Epidemiological study of Guillain-Barré syndrome in south east England", J Neurol Neurosurg Psychiatry, 64, pp.74~77 (1998)
33. Bersano A, "Long term disability and social status change after Guillain–Barré syndrome", J Neurol, 253, pp.214~218 (2006)
34. Bhagat SK, "Clinical profile, functional outcome, and mortality of Guillain-Barre syndrome : a five-year tertiary care experience from Nepal", Neurol Res Int, 2019, pp.3867946~ (2019)
35. Cheng BC, "Long-term prognosis for Guillain-Barré syndrome : evaluation of prognostic factors and clinical experience of automated double filtration plasmapheresis", J Clin Apher, 18, pp.175~180 (2003)
36. Alshekhlee A, "Guillain–Barré syndrome : incidence and mortality rates in US hospitals", Neurology, 70, pp.1608~1613 (2008)
37. Wong AHY, "The value of comparing mortality of Guillain–Barré syndrome across different regions", J Neurol Sci, 344, pp.60~62 (2014)
38. Stojanov A, "Incidence and mortality rates of Guillain-Barré syndrome in Serbia", J Peripher Nerv Syst, 25, pp.350~355 (2020)
39. Storey E, "Guillain-Barré syndrome and related conditions in Victorian teaching hospitals 1980–84", Aust N Z J Med, 19, pp.687~693 (1989)
40. Hankey GJ, "Guillain–Barré syndrome in Western Australia, 1980–1985", Med J Aust, 146, pp.130~133 (1987)
41. Hughes RA, "No association between immunization and Guillain-Barré syndrome in the United Kingdom, 1992 to 2000", Arch Intern Med, 166, pp.1301~1304 (2006)
42. Levison LS, "Guillain-Barré syndrome in Denmark : validation of diagnostic codes and a population-based nationwide study of the incidence in a 30-year period", Clin Epidemiol, 11, pp.275~283 (2019)
43. Lehmann HC, "Incidence of Guillain-Barré syndrome in Germany", J Peripher Nerv Syst, 12, pp.285~ (2007)
44. Kinnunen E, "Nationwide oral poliovirus vaccination campaign and the incidence of Guillain-Barré syndrome", Am J Epidemiol, 147, pp.69~73 (1998)
45. Sipilä JOT, "Epidemiology of Guillain-Barré syndrome in Finland 2004–2014", J Peripher Nerv Syst, 22, pp.440~445 (2017)
46. Benedetti MD, "A multicentric prospective incidence study of GuillainBarré syndrome in Italy. The ITANG study", Neuroepidemiology, 45, pp.90~99 (2015)
47. Beghi E, "The Guillain-Barrésyndrome(GBS)", Ital J Neurol Sci, 17, pp.355~361 (1996)
48. Chiò A, "Guillain-Barré syndrome : a prospective, population-based incidence and outcome survey", Neurology, 60, pp.1146~1150 (2003)
49. Larsen JP, "Epidemiology of the Guillain-Barrésyndrome in the county of Hordaland, Western Norway", Acta Neurol Scand, 71, pp.43~47 (1985)
50. Cuadrado JI, "Guillain-Barré syndrome in Spain, 1985–1997 : epidemiological and public health views", Eur Neurol, 46, pp.83~91 (2001)
51. McLean M, "Incidence of GuillainBarré syndrome in Ontario and Quebec, 1983–1989, using hospital service databases", Epidemiology, pp.443~448 (1994)

관련 논문AI추천